Hangover Remedies
APAC · 2 shared keywords
OTC & Nutraceuticals
APAC
APAC Ayurvedic Products Market Analysis, 2024–2034
Updated
Reviewed by Chandani Patel
Updated
Reviewed by Chandani Patel
APAC Ayurvedic Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$5.08 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $2.24 Bn | — | — |
| 2025 (base) | $2.54 Bn | +$291.8 Mn | — |
| 2026 (forecast) | $2.87 Bn | +$329.7 Mn | +13% |
| 2027 (forecast) | $3.24 Bn | +$372.6 Mn | +27.7% |
| 2028 (forecast) | $3.66 Bn | +$421.0 Mn | +44.3% |
| 2029 (forecast) | $4.14 Bn | +$475.8 Mn | +63% |
| 2030 (forecast) | $4.67 Bn | +$537.6 Mn | +84.2% |
| 2031 (forecast) | $5.28 Bn | +$607.5 Mn | +108.2% |
| 2032 (forecast) | $5.97 Bn | +$686.5 Mn | +135.3% |
| 2033 (forecast) | $6.74 Bn | +$775.7 Mn | +165.8% |
| 2034 (forecast) | $7.62 Bn | +$876.6 Mn | +200.4% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US
$5.57 Bn
China
$1.15 Bn
Canada
$1.09 Bn
Japan
$766.7 Mn
Germany
$489.3 Mn
UK
$381.3 Mn
France
$377.3 Mn
Brazil
$389.6 Mn
Ecuador
$319.3 Mn
Italy
$303.1 Mn
Spain
$273.6 Mn
Saudi Arabia
$234.4 Mn
India
$242.2 Mn
Mexico
$190.6 Mn
Australia
$193.0 Mn
Russia
$155.8 Mn
New Zealand
$119.6 Mn
South Africa
$97.0 Mn
UAE
$72.8 Mn
Egypt
$41.5 Mn
Philippines
$32.4 Mn
Malaysia
$23.1 Mn
Hong Kong
$19.9 Mn
Singapore
$16.9 Mn
Thailand
$14.6 Mn
Kenya
$9.7 Mn
| Market size, 2025 | $2.54 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $7.62 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 13.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, channel and distribution channel (see all) |
| Key players | Dabur, Patanjali Ayurved, Himalaya Wellness, Baidyanath, Kerala Ayurveda (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Ayurvedic products are traditional Indian herbal remedies, oils and supplements used for wellness and treatment.
Key segments of the ayurvedic Products market include product (Herbal Supplements, Personal Care and Medicines) and channel (Pharmacies, Supermarkets and Online).
Rising incomes, fast-growing private hospital chains, medical tourism, government health reforms and a young, digital-first population are driving the ayurvedic Products market.
Public-private partnerships, digital health and growing middle classes in Asia, the Middle East, Africa and Latin America give the ayurvedic Products market strong room to grow.
Uneven quality standards, limited insurance coverage, high out-of-pocket costs and regulatory differences between countries hold back the ayurvedic Products market.
The ayurvedic Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medicines are approved by TGA (Australia)[1], NMPA (China)[2], Drug Office (Hong Kong)[3], CDSCO (India)[4], PMDA (Japan)[5], NPRA (Malaysia)[6], Medsafe (New Zealand)[7], FDA Philippines (Philippines)[8], HSA (Singapore)[9] and Thai FDA (Thailand)[10]. In some of the countries we cover here, supplement rules come from TGA (Australia)[1], SAMR (China)[11], Centre for Food Safety (Hong Kong)[12], FSSAI (India)[13], Consumer Affairs Agency (Japan)[14], NPRA (Malaysia)[6], MPI (New Zealand)[15], FDA Philippines (Philippines)[8], HSA (Singapore)[9] and Thai FDA (Thailand)[10].
[1] Therapeutic Goods Administration. Checked 14 Nov 2026.
[2] National Medical Products Administration. Checked 14 Nov 2026.
[3] Drug Office, Department of Health. Checked 14 Nov 2026.
[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.
[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
[6] National Pharmaceutical Regulatory Agency. Checked 14 Nov 2026.
[7] Medsafe. Checked 14 Nov 2026.
[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.
[9] Health Sciences Authority. Checked 14 Nov 2026.
[10] Thai Food and Drug Administration. Checked 14 Nov 2026.
[11] State Administration for Market Regulation. Checked 14 Nov 2026.
[12] Centre for Food Safety. Checked 14 Nov 2026.
[13] Food Safety and Standards Authority of India. Checked 14 Nov 2026.
[14] Consumer Affairs Agency. Checked 14 Nov 2026.
[15] Ministry for Primary Industries. Checked 14 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern ayurvedic Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in APAC.
What doctors and scientists are doing in Ayurvedic Products right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
APAC · 2 shared keywords
APAC · 2 shared keywords
APAC · 2 shared keywords
APAC · 1 shared keyword
APAC · 1 shared keyword
APAC · 1 shared keyword
Pharmaceuticals · APAC
Pharmaceuticals · APAC
Pharmaceuticals · APAC
Medical Devices · APAC
Public Health · Global
Public Health · Global